-
Treatment with Ceftazidime-Avibactam for Lower Respiratory Tract Infections Caused by the Multidrug-Resistant Gram-Negative Bacteria in the Intensive Care Unit
05 Apr 2025 08:44 GMT
… Table 2 Infection and Medication Characteristics of Patients With … than other conventional drugs in the treatment of MDR- … versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia … in an individual with cystic fibrosis: a case report. …
-
Positive Interim Results on Trontinemab Validate Brainshuttle Technology for Alzheimer Disease Treatment
05 Apr 2025 01:16 GMT
Roche presented interim trial data for trontinemab, a … paired with effective disease-modifying treatments to slow neurodegeneration as … plaque elimination — safely. First Word Pharma. April 3, 2025. Accessed … -amyloid-beta-mabs/?cf-view
3. Roche presents …
-
Cimplrx and Samjin Pharmaceutical describe new ENPP1 inhibitors
02 Apr 2025 18:46 GMT
… Cimplrx Co. Ltd. and Samjin Pharmaceutical Co. Ltd. have identified ectonucleotide … useful for the treatment of cancer, hypophosphatemia, osteoarthritis, cystic fibrosis, type 2 diabetes …
-
New Alzheimer’s treatment targets root causes, not just symptoms
02 Apr 2025 09:56 GMT
… shift in the approach to treating the disease, targeting its root … to revolutionise our approach to treating Alzheimer’s disease, instilling renewed … ’ new treatment for cystic fibrosis was granted Orphan Drug Designation by the FDA in 2025 …
-
Jim Cramer on Vertex Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!”
02 Apr 2025 01:32 GMT
… Pharmaceuticals (VRTX): “Revolutionary Pain Drug on the Horizon!” A pharmacist delivering a specific medication … to a patient in a specialty pharmacy. Number … in creating and promoting treatments for cystic fibrosis (CF) and is advancing a …
-
Is Vertex Pharmaceuticals Incorporated (VRTX) the Best Gene-Editing Stock to Buy?
01 Apr 2025 16:47 GMT
… FDA-cleared in vivo gene-editing trial … treatments for genetic diseases, especially cystic fibrosis, and generates revenue by selling medications … CF treatments and the launch of CASGEVY. Vertex Pharmaceuticals … company aims to treat millions of patients …
-
Orphan drugs will double their market share by 2030
31 Mar 2025 18:05 GMT
… ;deutivacaftor). Vertex Pharmaceuticals' cystic fibrosis therapy for patients … treatments in terms of sales and market penetration.
Pipeline innovation
The orphan drug … difficult-to-treat forms of … between orphan drugs and traditional medications fades, …
-
10 Best Health Care Stocks to Buy for 2025
05 Apr 2025 00:05 GMT
… portfolio of drugs for treating a variety of conditions. Its top drugs include … Pharmaceuticals is a biopharmaceutical company that specializes in developing therapies to treat cystic fibrosis …
-
Meet the Penn people who fix problems with tech and ingenuity
04 Apr 2025 13:20 GMT
… college as a pre-med student and minored in … cancer, cystic fibrosis, and autoimmune diseases. It typically took pharmacy staff making … patients because these are medications that are more or … version specifically for weight loss drugs. Called GLP-1 Refill …
-
7 Top Gene-Editing Stocks to Buy
04 Apr 2025 17:40 GMT
… -name prescription drugs to treat a wide … Pharmaceuticals is a biopharmaceutical company that specializes in developing therapies to treat cystic fibrosis (CF … Food and Drug Administration for treating sickle cell … s NTLA-2002 treatment for hereditary angioedema …